文献速递糖尿病

一级亲属糖尿病家族史对DPP/DPPOS长期随访中糖尿病发病的影响

Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.
PubMed 文献 · Diabetes Care · 2025-01-01

本研究基于DPP/DPPOS中3072例糖尿病前期成人,中位随访21年,分析一级亲属家族史与糖尿病发病的关系。调整人口学、临床变量、干预组及多基因风险评分后,任何家族史的HR为1.21(95%CI 1.06,1.38),父母双方均有病史的HR为1.44(1.22,1.69)。多基因风险评分仅解释32%的关联,提示罕见变异、家族和环境因素也参与风险。

要点

  • 一级亲属糖尿病家族史使糖尿病前期人群发病风险增加21%。
  • 父母双方均有糖尿病史的风险(HR 1.44)高于单亲史(HR 1.22)。
  • 多基因风险评分仅解释32%的家族史关联,残余风险需综合评估。

核心结论

  • 控制DPP干预分组后,父母糖尿病史仍增加2型糖尿病风险,且该效应仅部分由多基因风险评分解释。

研究设计与样本

  • DPP将糖尿病前期成人随机分配至强化生活方式、二甲双胍或安慰剂,88%合格参与者续入DPPOS长期随访。
  • 本分析纳入3072例有家族史信息的参与者,中位随访21年,其中1975例有父母史、226例仅有兄弟姐妹史、871例无家族史。

主要发现

  • 调整人口学、临床变量、DPP随机分组及多基因风险评分后,任何家族史的HR为1.21(95%CI 1.06,1.38),父母史HR为1.19(1.04,1.35),兄弟姐妹史HR为1.15(0.91,1.44)。
  • 父母双方均有糖尿病史的HR为1.44(95%CI 1.22,1.69),高于仅母亲(1.22 [1.08,1.38])或仅父亲(1.22 [1.08,1.39])有糖尿病史。
  • 多基因风险评分解释了任何家族史与糖尿病风险关联的32%。

关键数值与推荐

  • 糖尿病发病依据美国糖尿病协会(ADA)标准判定。

临床怎么用

  • 对糖尿病前期患者应详细采集一级亲属糖尿病史,尤其父母双方均有病史者风险更高。
  • 家族史风险不能完全由多基因风险评分替代,临床评估需结合家族史和环境因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the effects of first-degree family history of diabetes on diabetes incidence in Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS) participants. RESEARCH DESIGN AND METHODS: In the DPP, adults with prediabetes were randomized to an intensive lifestyle intervention, metformin, or placebo and followed for incident diabetes. On study completion 88% of eligible DPP participants reenrolled in DPPOS for long-term follow-up. The present analysis includes all 3,072 participants with family history information through DPPOS, with a median follow-up of 21 years (1,975 had parental history of diabetes [PH] [312 biparental, 947 maternal, 716 paternal], 226 had only sibling history [SH], and 871 denied any family history). The primary outcome is incident diabetes based on American Diabetes Association criteria, with adjustment for demographic and clinical variables, DPP randomization arm, and polygenic risk score (PRS). RESULTS: Adjusted hazard ratio (HR) was 1.21 (95% CI 1.06, 1.38) for any family history, 1.19 (1.04, 1.35) for PH, and 1.15 (0.91, 1.44) for SH. Biparental history conferred greater hazard (HR 1.44 [95% CI 1.22, 1.69]) than maternal (1.22 [1.08, 1.38]) or paternal (1.22 [1.08, 1.39]) diabetes history alone. PRS explained 32% of the association of any family history with diabetes risk. CONCLUSIONS: PH increased type 2 diabetes risk after DPP treatment group was controlled for. That effect was only partially explained by PRS, suggesting that rare gene variants, familial, and environmental factors may contribute to type 2 diabetes risk in people with prediabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Dagogo-Jack S, Kazemi EJ, Doherty L, et al. Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025. PMID: 40882001. doi:10.2337/dc25-0633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。